SCHEMBL201115

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2706591	0.89	PPARD (0.39)	PPARDRIPK2FFAR1MAPK14CTSA
	SCHEMBL202352	0.89	PPARD (0.46)	PPARD
	SCHEMBL202797	0.87	PPARD (0.51)	PPARD
	SCHEMBL201593	0.86	PPARD (0.38)	PPARD
	SCHEMBL201522	0.83	NPC1 (0.42)	PPARDFFAR1MAPTPPARA
	SCHEMBL4567006	0.83	PPARD (0.36)	PPARDPTGDR2FFAR1
	SCHEMBL16886207	0.83	PTGDR2 (0.35)	PPARDPTGDR2
	SCHEMBL202833	0.83	POLB (0.53)	PPARDMAPTL3MBTL1PPARA
	SCHEMBL2704709	0.82	PTGDR2 (0.43)	PPARDPTGDR2
	SCHEMBL201617	0.81	PPARD (0.51)	PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.